The DOI matches its Crossref record.
Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy
Abstract
Severe coagulopathy in fulminant hepatic failure (FHF) is difficult to correct by conventional means. Recombinant activated factor VII (rFVIIa) is an antihemophilic factor that has shown promise in treating coagulopathy in liver disease. Our aim is to review our experience with rFVIIa in treating the coagulopathy of FHF and compare these results with those of conventional therapy. Fifteen patients with FHF who met King’s College criteria for orthotopic liver transplantation were studied. All were ascertained from our liver disease registry. Eight consecutive patients were administered fresh frozen plasma (FFP) alone, whereas seven consecutive patients were administered FFP and rFVIIa (40 μg/kg intravenous bolus). The two groups, with similar demographic characteristics, were compared in terms of measured parameters of coagulopathy (prothrombin time and international normalized ratio), amount of plasma infused, development of anasarca, ability to undergo intracranial pressure (ICP) transducer placement, bleeding complications, ability to undergo transplantation, and survival. All patients administered rFVIIa (after a single dose) versus none administered FFP alone had temporary (2- to 6-hour) correction of coagulopathy (P < .0002). All patients administered rFVIIa versus 38% administered FFP alone were able to have an ICP transducer placed (P = .03). The rFVIIa group had less anasarca (P = .04). An equal number of patients underwent transplantation from each group, but overall survival was slightly better in the rFVIIa group (P = .04). Five of seven patients in the rFVIIa group were administered one or more subsequent doses of rFVIIa after placement of the ICP monitor (two patients, for additional procedures; three patients, prophylactically in the first 24 hours after ICP transducer placement) at the discretion of the attending physicians. We conclude that rFVIIa is effective in transiently correcting laboratory parameters of coagulopathy in patients with FHF. It facilitates the performance of invasive procedures and is associated with less frequent anasarca compared with conventional therapy. Our preliminary experience supports the need for further studies to define the optimal dosing, safety, and efficacy of rFVIIa in patients with FHF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
AASLD position paper: The management of acute liver failure†
Polson, J., & Lee, W. M. (2005) · Hepatology · doi:10.1002/hep.20703 · Cited by 974
Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology
Kozek-Langenecker, S. A., Afshari, A., Albaladejo, P., Santullano, C. A. A., De Robertis, E., Filipescu, D. C., Fries, D., Görlinger, K., Haas, T., Imberger, G., et al. (2013) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32835f4d5b · Cited by 909
Lee, W. M., Stravitz, T. R., & Larson, A. M. (2012) · Hepatology · doi:10.1002/hep.25551 · Cited by 550
Stravitz, R. T., Kramer, A. H., Davern, T., Shaikh, A. O. S., Caldwell, S. H., Mehta, R. L., Blei, A. T., Fontana, R. J., McGuire, B. M., Rossaro, L., et al. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000287592.94554.5f · Cited by 422
Self-citationVaquero, J., Fontana, R. J., Larson, A. M., Bass, N. M. T., Davern, T. J., Shakil, O. A., Han, S., Harrison, E. M., Stravitz, T. R., Muñoz, S., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20625 · Cited by 304
Metadata
- Authors
- Shami, V. M., Caldwell, S. H., Hespenheide, E. E., Arseneau, K. O., Bickston, S. J., & Macik, G. B.
- Venue
- Liver Transplantation
- Published
- 2003-02
- Volume
- 9
- Issue
- 2
- Pages
- 138-143
- ISSN
- 1527-6465 (ISSN-L)
- OpenAlex
- W2028757573
- Cited by
- 237
- References
- 0
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. https://app.cochat.ai/papers/10.1053/jlts.2003.50017
- The paper
- Shami, V. M., Caldwell, S. H., Hespenheide, E. E., Arseneau, K. O., Bickston, S. J., & Macik, G. B. (2003). Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transplantation. https://doi.org/10.1053/jlts.2003.50017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.